Kairos Pharma raises $3.5M in PIPE offering at $1.40/unit with warrants

Kairos Pharma, LTD.

Raises $3.5M gross from sale of units at $1.40/Common Unit and $1.399/Pre-Funded Unit.
Each Common Unit includes 1 share and 1.5 Common Warrants exercisable at $1.40 for 5.5 years.
Insiders enter 90-day lock-up; registration rights for resale of shares and warrant shares.
Closing expected January 15, 2025; D. Boral Capital and Boustead Securities as co-placement agents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.